Canvas
On October 26, Amazon received approval for wholesale pharmacy licenses in 12 states (cnbc.com). Since then, prices of U.S. pharmacy stocks have plummeted by an average of 8%: Rite Aid (-14%), McKesson (-10%), Cardinal Health (-10%), CVS Health (-9%), AmerisourceBergen (-9%), Walgreens (-2%) and Express Scripts (-1%). As a foreshadowing of how Amazon could leverage AI to disrupt the pharmacy ecosystem, pharmacists could be the next professionals at risk of being displaced by robots. In China, Midea Group, the world's largest appliance maker is partnering on a pilot program with Guangzhou Pharmaceuticals to bring fully automated dispensaries to thousands of health care institutions, drugstores and retailers (bloomberg.com).
We are creators of independent equity research. The Pennock Idea Hub team are veterans of the investment industry. Much of our team has spent their careers at Merrill Lynch, Deutsche Bank, RBC Capital Markets and Wood Gundy. We have taken every aspect of research back to the studs and returned to first principles. The Pennock Idea Hub marries the interests of the sell and buy side.
We offer the best research for institutional investors by:
- Only publishing research from veteran analysts
- Eliminate the inherent conflicts of the traditional sell and buy side relationship
- Ensure our team is always accessible; collaboration with clients nurtures our collective success
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.